---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-096532"
form_type: "8-K"
ticker: "APTN"
cik: "0001938571"
company_name: "ADAPTIN BIO, INC."
filed_at: "2025-10-06T23:59:59+00:00"
generated_at: "2026-05-17T04:38:31.095008+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Adaptin Bio increases CFO salary to $300k full-time; CDO salary to $150k at 50% commitment

## Summary
- CFO Timothy Maness moved to full-time from 80%; base salary raised from $240k to $300k, retroactive to July 1, 2025.
- CDO L. Arthur Hewitt commitment increased from 25% to 50%; salary doubled to $150k annually, effective October 3, 2025.
- Hewitt amendment includes anti-dilution option grant if company raises $10M within two years of February 11, 2025 merger.
- Both amendments effective as of specified dates; no other material changes to employment terms.

## SEC filing metadata
- accession: 0001213900-25-096532
- form_type: 8-K
- ticker: APTN
- cik: 0001938571
- company_name: ADAPTIN BIO, INC.
- filed_at: 2025-10-06T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1938571/000121390025096532/0001213900-25-096532-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1938571/000121390025096532/ea0260272-8k_adaptin.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-096532
- JSON: https://secwatch.observer/filing/0001213900-25-096532.json
- Plain text: https://secwatch.observer/filing/0001213900-25-096532.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.